All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Astellas Pharma Inc. revenue reports

Astellas Pharma Inc. financial reports, Astellas Pharma Inc. annual revenue in 2020. When does Astellas Pharma Inc. report revenue?
Add to widgets
Added to widgets

Astellas Pharma Inc. total revenue, net income and dynamics of changes in US dollar today

Astellas Pharma Inc. revenue for the past few reporting periods. The dynamics of net income of Astellas Pharma Inc. has changed by -8 515 000 000 $ in recent years. These are the main financial indicators of Astellas Pharma Inc.. Graph of finance company Astellas Pharma Inc.. The financial schedule of Astellas Pharma Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. Information on Astellas Pharma Inc. net income on the chart on this page is drawn in blue bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 338 065 000 000 $ -5.55 % ↓ 61 494 000 000 $ -29.857 % ↓
30/09/2019 316 336 000 000 $ -0.527 % ↓ 70 009 000 000 $ +41.99 % ↑
30/06/2019 334 134 000 000 $ +1.53 % ↑ 58 518 000 000 $ +7.26 % ↑
31/03/2019 301 320 000 000 $ - 30 730 000 000 $ -
31/12/2018 357 932 000 000 $ - 87 669 000 000 $ -
30/09/2018 318 011 000 000 $ - 49 307 000 000 $ -
30/06/2018 329 085 000 000 $ - 54 559 000 000 $ -
Show:
to

Astellas Pharma Inc. financial report charts

The dates of the latest financial statements of Astellas Pharma Inc.: 30/06/2018, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Astellas Pharma Inc. for today is 31/12/2019. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 255 295 000 000 $

Astellas Pharma Inc. quarterly report dates

Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 82 770 000 000 $ Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 338 065 000 000 $ Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 76 154 000 000 $

Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is 61 494 000 000 $ Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 834 150 000 000 $ Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 1 989 779 000 000 $

31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
255 295 000 000 $ 247 976 000 000 $ 263 622 000 000 $ 236 981 000 000 $ 273 761 000 000 $ 245 207 000 000 $ 258 349 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
82 770 000 000 $ 68 360 000 000 $ 70 512 000 000 $ 64 339 000 000 $ 84 171 000 000 $ 72 804 000 000 $ 70 736 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
338 065 000 000 $ 316 336 000 000 $ 334 134 000 000 $ 301 320 000 000 $ 357 932 000 000 $ 318 011 000 000 $ 329 085 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
76 154 000 000 $ 85 788 000 000 $ 77 815 000 000 $ 71 943 000 000 $ 83 030 000 000 $ 63 643 000 000 $ 63 801 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
61 494 000 000 $ 70 009 000 000 $ 58 518 000 000 $ 30 730 000 000 $ 87 669 000 000 $ 49 307 000 000 $ 54 559 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
54 780 000 000 $ 51 467 000 000 $ 53 507 000 000 $ 58 723 000 000 $ 50 393 000 000 $ 47 433 000 000 $ 52 132 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
261 911 000 000 $ 230 548 000 000 $ 256 319 000 000 $ 229 377 000 000 $ 274 902 000 000 $ 254 368 000 000 $ 265 284 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
834 150 000 000 $ 855 596 000 000 $ 820 130 000 000 $ 857 159 000 000 $ 890 258 000 000 $ 845 514 000 000 $ 844 734 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 989 779 000 000 $ 1 979 816 000 000 $ 1 927 031 000 000 $ 1 897 648 000 000 $ 1 928 325 000 000 $ 1 886 926 000 000 $ 1 866 551 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
277 602 000 000 $ 311 367 000 000 $ 259 422 000 000 $ 311 074 000 000 $ 331 296 000 000 $ 306 867 000 000 $ 309 741 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
466 058 000 000 $ 483 626 000 000 $ 464 162 000 000 $ 495 759 000 000 $ 494 592 000 000 $ 447 580 000 000 $ 438 647 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
672 333 000 000 $ 683 681 000 000 $ 677 323 000 000 $ 639 252 000 000 $ 636 116 000 000 $ 604 241 000 000 $ 590 630 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
33.79 % 34.53 % 35.15 % 33.69 % 32.99 % 32.02 % 31.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 317 446 000 000 $ 1 296 135 000 000 $ 1 249 708 000 000 $ 1 258 396 000 000 $ 1 292 209 000 000 $ 1 282 685 000 000 $ 1 275 921 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
68 631 000 000 $ 94 247 000 000 $ 7 412 000 000 $ 54 949 000 000 $ 91 595 000 000 $ 74 907 000 000 $ 37 179 000 000 $

Last revenue report of Astellas Pharma Inc. was 31/12/2019. According to last financial report total revenue in Astellas Pharma Inc. was 338 065 000 000 US dollar and changed by -5.55% since last year. Net income in Astellas Pharma Inc. was 61 494 000 000 $ in last quartal, net income changes to -29.857%.

Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 277 602 000 000 $ Current debt Astellas Pharma Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Astellas Pharma Inc. is 466 058 000 000 $ Total debt Astellas Pharma Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Astellas Pharma Inc. is 672 333 000 000 $

Astellas Pharma Inc. stocks data

Astellas Pharma Inc. financials